American Conference Institute’s Summit on U.S. Biosimilars

As the first biosimilars become a reality in the U.S., ACI is bringing its flagship biosimilars event to the EU companies who will be doing business in the U.S.  Goodwin Procter partner Elaine Blais is speaking on the panel "Biosimilars Litigation Spotlight: Immediate Action Plans for Innovators and Biosimilars to Prepare For the Battles to Come," that will review the BPCIA cases filed to date and analyze the substantive arguments in the cases.

See event website for additional information.